Asked by: Nicholas Dakin (Labour - Scunthorpe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the incidence of atopic dermatitis on (a) patients’ out of pocket expenses, (b) lost work days and (c) mental health services.
Answered by Seema Kennedy
The commissioning and configuration of dermatology services in England is a local matter. The majority of patients with dermatological disorders are managed in primary and community care and the local National Health Service is best placed to make decisions that ensure services meet the needs of resident populations in the most appropriate way.
The National Institute for Health and Care Excellence has published guidance on a number of dermatological conditions, including eczema, also known as atopic dermatitis, to support commissioners to plan and deliver services for local populations. ‘Atopic eczema in under 12’s: diagnosis and management’ includes recommendations that healthcare professionals should adopt a holistic approach at each consultation, taking into account severity of a condition and the impact this may have on quality of life.
Healthcare professionals should be aware that all categories of severity of atopic eczema, even mild, can have a negative impact on psychological and psychosocial wellbeing and quality of life and that assessment of wellbeing should be carried out at every consultation. Furthermore, the guidance recommends using validated tools in the management of patients, such as Children's Dermatology Life Quality Index, Infants' Dermatitis Quality of Life Index or Dermatitis Family Impact questionnaire for quality of life. Where quality of life and psychosocial wellbeing has not improved despite treatment and improvement, patients should be referred for psychological advice. The guidance can be found at the following link:
As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England is taking action in range of areas to improve the care treatment and support provided to people with long term conditions. As part of this, it is continuing its expansion of Improving Access to Psychological Therapies (IAPT) services for adults with common mental health problems, with a focus on those with long-term conditions. IAPT services have now evolved to deliver benefits to people with long-term conditions, providing genuinely integrated care. By 2023/24, an additional 380,000 adults will be able to access IAPT services.
No assessment has been made on the impact of atopic dermatitis on patient expenses, work days and mental health services. No meetings regarding atopic dermatitis have taken place in the last 12 months.
Asked by: Nicholas Dakin (Labour - Scunthorpe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans he has to support the provision of psychodermatology services across England.
Answered by Seema Kennedy
The commissioning and configuration of dermatology services in England is a local matter. The majority of patients with dermatological disorders are managed in primary and community care and the local National Health Service is best placed to make decisions that ensure services meet the needs of resident populations in the most appropriate way.
The National Institute for Health and Care Excellence has published guidance on a number of dermatological conditions, including eczema, also known as atopic dermatitis, to support commissioners to plan and deliver services for local populations. ‘Atopic eczema in under 12’s: diagnosis and management’ includes recommendations that healthcare professionals should adopt a holistic approach at each consultation, taking into account severity of a condition and the impact this may have on quality of life.
Healthcare professionals should be aware that all categories of severity of atopic eczema, even mild, can have a negative impact on psychological and psychosocial wellbeing and quality of life and that assessment of wellbeing should be carried out at every consultation. Furthermore, the guidance recommends using validated tools in the management of patients, such as Children's Dermatology Life Quality Index, Infants' Dermatitis Quality of Life Index or Dermatitis Family Impact questionnaire for quality of life. Where quality of life and psychosocial wellbeing has not improved despite treatment and improvement, patients should be referred for psychological advice. The guidance can be found at the following link:
As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England is taking action in range of areas to improve the care treatment and support provided to people with long term conditions. As part of this, it is continuing its expansion of Improving Access to Psychological Therapies (IAPT) services for adults with common mental health problems, with a focus on those with long-term conditions. IAPT services have now evolved to deliver benefits to people with long-term conditions, providing genuinely integrated care. By 2023/24, an additional 380,000 adults will be able to access IAPT services.
No assessment has been made on the impact of atopic dermatitis on patient expenses, work days and mental health services. No meetings regarding atopic dermatitis have taken place in the last 12 months.
Asked by: Nicholas Dakin (Labour - Scunthorpe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many meetings his Department has had with (a) patient and (b) professional atopic dermatitis groups in the last 12 months.
Answered by Seema Kennedy
The commissioning and configuration of dermatology services in England is a local matter. The majority of patients with dermatological disorders are managed in primary and community care and the local National Health Service is best placed to make decisions that ensure services meet the needs of resident populations in the most appropriate way.
The National Institute for Health and Care Excellence has published guidance on a number of dermatological conditions, including eczema, also known as atopic dermatitis, to support commissioners to plan and deliver services for local populations. ‘Atopic eczema in under 12’s: diagnosis and management’ includes recommendations that healthcare professionals should adopt a holistic approach at each consultation, taking into account severity of a condition and the impact this may have on quality of life.
Healthcare professionals should be aware that all categories of severity of atopic eczema, even mild, can have a negative impact on psychological and psychosocial wellbeing and quality of life and that assessment of wellbeing should be carried out at every consultation. Furthermore, the guidance recommends using validated tools in the management of patients, such as Children's Dermatology Life Quality Index, Infants' Dermatitis Quality of Life Index or Dermatitis Family Impact questionnaire for quality of life. Where quality of life and psychosocial wellbeing has not improved despite treatment and improvement, patients should be referred for psychological advice. The guidance can be found at the following link:
As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England is taking action in range of areas to improve the care treatment and support provided to people with long term conditions. As part of this, it is continuing its expansion of Improving Access to Psychological Therapies (IAPT) services for adults with common mental health problems, with a focus on those with long-term conditions. IAPT services have now evolved to deliver benefits to people with long-term conditions, providing genuinely integrated care. By 2023/24, an additional 380,000 adults will be able to access IAPT services.
No assessment has been made on the impact of atopic dermatitis on patient expenses, work days and mental health services. No meetings regarding atopic dermatitis have taken place in the last 12 months.
Asked by: Nicholas Dakin (Labour - Scunthorpe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure patient experience is at the heart of commissioning for adult atopic dermatitis services in England.
Answered by Seema Kennedy
The commissioning and configuration of dermatology services in England is a local matter. The majority of patients with dermatological disorders are managed in primary and community care and the local National Health Service is best placed to make decisions that ensure services meet the needs of resident populations in the most appropriate way.
The National Institute for Health and Care Excellence has published guidance on a number of dermatological conditions, including eczema, also known as atopic dermatitis, to support commissioners to plan and deliver services for local populations. ‘Atopic eczema in under 12’s: diagnosis and management’ includes recommendations that healthcare professionals should adopt a holistic approach at each consultation, taking into account severity of a condition and the impact this may have on quality of life.
Healthcare professionals should be aware that all categories of severity of atopic eczema, even mild, can have a negative impact on psychological and psychosocial wellbeing and quality of life and that assessment of wellbeing should be carried out at every consultation. Furthermore, the guidance recommends using validated tools in the management of patients, such as Children's Dermatology Life Quality Index, Infants' Dermatitis Quality of Life Index or Dermatitis Family Impact questionnaire for quality of life. Where quality of life and psychosocial wellbeing has not improved despite treatment and improvement, patients should be referred for psychological advice. The guidance can be found at the following link:
As set out in the NHS Long Term Plan, published on 7 January 2019, NHS England is taking action in range of areas to improve the care treatment and support provided to people with long term conditions. As part of this, it is continuing its expansion of Improving Access to Psychological Therapies (IAPT) services for adults with common mental health problems, with a focus on those with long-term conditions. IAPT services have now evolved to deliver benefits to people with long-term conditions, providing genuinely integrated care. By 2023/24, an additional 380,000 adults will be able to access IAPT services.
No assessment has been made on the impact of atopic dermatitis on patient expenses, work days and mental health services. No meetings regarding atopic dermatitis have taken place in the last 12 months.
Asked by: Nicholas Dakin (Labour - Scunthorpe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department supports the prioritisation of atopic dermatitis in adults as a topic for guideline development by NICE.
Answered by Seema Kennedy
NHS England is the principal commissioner of clinical guidelines and National Health Service related quality standards from the National Institute for Health and Care Excellence (NICE).
NICE and NHS England have been in discussion about developing a clinical guideline and quality standard on atopic dermatitis (eczema) in adults. NHS England has recently consulted on a draft policy which included the prescribing of emollient bath and shower preparations for dry and pruritic skin conditions and will consider the appropriateness of referring a guideline on atopic dermatitis in adults to NICE after the consultation responses have been reviewed.
Details of this can be seen in the consultation document at the following link:
Asked by: Nicholas Dakin (Labour - Scunthorpe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps are being taken by (a) his Department, (b) NHS England and (c) NICE to ensure there is a NICE clinical guideline and quality standard in place for atopic dermatitis in adults.
Answered by Seema Kennedy
NHS England is the principal commissioner of clinical guidelines and National Health Service related quality standards from the National Institute for Health and Care Excellence (NICE).
NICE and NHS England have been in discussion about developing a clinical guideline and quality standard on atopic dermatitis (eczema) in adults. NHS England has recently consulted on a draft policy which included the prescribing of emollient bath and shower preparations for dry and pruritic skin conditions and will consider the appropriateness of referring a guideline on atopic dermatitis in adults to NICE after the consultation responses have been reviewed.
Details of this can be seen in the consultation document at the following link:
Asked by: Nicholas Dakin (Labour - Scunthorpe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the implications for his policies of the 2017 World Health Organization report on sunbeds which found that more than 10,000 melanoma cases each year in the United States of America, Europe and Australia are attributed to sunbed use; and if will make an assessment of the potential merits of making it compulsory for all local authorities to have regulated licensing schemes for sunbed premises.
Answered by Jackie Doyle-Price
Public Health England (PHE) contributed to the revision of the World Health Organization report, ‘Artificial tanning devices: public health interventions to manage sunbeds’, the thrust of which is in line with PHE advice and the recommendations of the 13th report of the Committee on Medical Aspects of Radiation in the Environment (COMARE) at the following link:
https://www.gov.uk/government/publications/comare-13th-report
The Sunbeds Regulation Act 2010 was implemented to prohibit under-18s from using sunbeds based on the COMARE recommendations.
The Department and the Health and Safety Executive (HSE) have published guidance to support the enforcement of the regulations by local authorities and safe use of sunbeds at the following links:
http://www.hse.gov.uk/pubns/indg209.pdf
PHE is currently refreshing its guidance on the use of sunbeds. PHE’s current advice is available to view at the following link:
https://www.gov.uk/government/publications/sunbeds-safety-advice
The Department is considering whether current measures are effective for protecting sunbed users.